相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The mycobacterial cell envelope - a moving target
Charles L. Dulberger et al.
NATURE REVIEWS MICROBIOLOGY (2020)
Beyond antibiotics for pulmonary nontuberculous mycobacterial disease
Grant Waterer
CURRENT OPINION IN PULMONARY MEDICINE (2020)
Electrochemistry of ring-substituted 1-hydroxynaphthalene-2-carboxanilides: Relation to structure and biological activity
Julius Gajdar et al.
ELECTROCHIMICA ACTA (2020)
Non-tuberculous mycobacteria and the rise of Mycobacterium abscessus
Matt D. Johansen et al.
NATURE REVIEWS MICROBIOLOGY (2020)
Macrophage Signaling Pathways in Pulmonary Nontuberculous Mycobacteria Infections
Zohra Prasla et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2020)
Active Benzimidazole Derivatives Targeting the MmpL3 Transporter in Mycobacterium abscessus
Clement Raynaud et al.
ACS INFECTIOUS DISEASES (2020)
New tuberculosis drug targets, their inhibitors, and potential therapeutic impact
Gauri S. Shetye et al.
TRANSLATIONAL RESEARCH (2020)
Identification and drug susceptibility testing for nontuberculous mycobacteria
Wei-Chang Huang et al.
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION (2020)
Structure-Based Design and Synthesis of Piperidinol-Containing Molecules as New Mycobacterium abscessus Inhibitors
Jerome de Ruyck et al.
CHEMISTRYOPEN (2020)
Potency Increase of Spiroketal Analogs of Membrane Inserting Indolyl Mannich Base Antimycobacterials Is Due to Acquisition of MmpL3 Inhibition
Ming Li et al.
ACS INFECTIOUS DISEASES (2020)
Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline: Executive Summary
Charles L. Daley et al.
CLINICAL INFECTIOUS DISEASES (2020)
Design, synthesis, and biological evaluation of novel arylcarboxamide derivatives as anti-tubercular agents
Shahinda S. R. Alsayed et al.
RSC ADVANCES (2020)
Rifabutin Suppresses Inducible Clarithromycin Resistance in Mycobacterium abscessus by Blocking Induction of whiB7 and erm41
Dinah Binte Aziz et al.
ANTIBIOTICS-BASEL (2020)
Crystal Structures of Membrane Transporter MmpL3, an Anti-TB Drug Target
Bing Zhang et al.
CELL (2019)
Mycobacterium abscessus pulmonary disease: individual patient data meta-analysis
Nakwon Kwak et al.
EUROPEAN RESPIRATORY JOURNAL (2019)
Identification of Novel Coumestan Derivatives as Polyketide Synthase 13 Inhibitors against Mycobacterium tuberculosis. Part II
Wei Zhang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Direct Inhibition of MmpL3 by Novel Antitubercular Compounds
Wei Li et al.
ACS INFECTIOUS DISEASES (2019)
Advancing the Therapeutic Potential of Indoleamides for Tuberculosis
Shichun Lun et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
MmpL3 is a lipid transporter that binds trehalose monomycolate and phosphatidylethanolamine
Chih-Chia Su et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Chemical disarming of isoniazid resistance in Mycobacterium tuberculosis
Kelly Flentie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
1H-Benzo[d]Imidazole Derivatives Affect MmpL3 in Mycobacterium tuberculosis
Malgorzata Korycka-Machala et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Bedaquiline Eliminates Bactericidal Activity of β-Lactams against Mycobacterium abscessus
Marissa Lindman et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Antimycobacterial Susceptibility Testing of Nontuberculous Mycobacteria
Barbara A. Brown-Elliott et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2019)
The MmpL3 interactome reveals a complex crosstalk between cell envelope biosynthesis and cell elongation and division in mycobacteria
Juan Manuel Belardinelli et al.
SCIENTIFIC REPORTS (2019)
Editorial: NTM-The New Uber-Bugs
Veronique Dartois et al.
FRONTIERS IN MICROBIOLOGY (2019)
Identification of New MmpL3 Inhibitors by Untargeted and Targeted Mutant Screens Defines MmpL3 Domains with Differential Resistance
John T. Williams et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Novel Pyrazole-Containing Compounds Active against Mycobacterium tuberculosis
Giovanna Poce et al.
ACS MEDICINAL CHEMISTRY LETTERS (2019)
Mycobacterium abscessus, an Emerging and Worrisome Pathogen among Cystic Fibrosis Patients
Giulia Degiacomi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
A piperidinol-containing molecule is active against Mycobacterium tuberculosis by inhibiting the mycolic acid flippase activity of MmpL3
Christian Dupont et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
Identification of novel scaffolds targeting Mycobacterium tuberculosis
Michael Dal Molin et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2019)
Rifabutin Acts in Synergy and Is Bactericidal with Frontline Mycobacterium abscessus Antibiotics Clarithromycin and Tigecycline, Suggesting a Potent Treatment Combination
Mark Pryjma et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
HC2091 Kills Mycobacterium tuberculosis by Targeting the MmpL3 Mycolic Acid Transporter
Huiqing Zheng et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
NTM drug discovery: status, gaps and the way forward
Mu-Lu Wu et al.
DRUG DISCOVERY TODAY (2018)
Indolyl Azaspiroketal Mannich Bases Are Potent Antimycobacterial Agents with Selective Membrane Permeabilizing Effects and in Vivo Activity
Samuel Agyei Nyantakyi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
NonTuberculous Mycobacteria infection and lung transplantation in cystic fibrosis: a worldwide survey of clinical practice
Adrien Tissot et al.
BMC PULMONARY MEDICINE (2018)
MmpL3 as a Target for the Treatment of Drug-Resistant Nontuberculous Mycobacterial Infections
Wei Li et al.
FRONTIERS IN MICROBIOLOGY (2018)
Discovery of benzothiazole amides as potent antimycobacterial agents
James Graham et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2018)
Discovery of heterocyclic replacements for the coumarin core of anti-tubercular FadD32 inhibitors
Chao Fang et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2018)
Optimization and Lead Selection of Benzothiazole Amide Analogs Toward a Novel Antimycobacterial Agent
Mary A. De Groote et al.
FRONTIERS IN MICROBIOLOGY (2018)
A description of Mycobacterium chelonae subsp. gwanakae subsp. nov., a rapidly growing mycobacterium with a smooth colony phenotype due to glycopeptidolipids
Byoung-Jun Kim et al.
INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY (2018)
Novel Acetamide Indirectly Targets Mycobacterial Transporter MmpL3 by Proton Motive Force Disruption
Annanya Shetty et al.
FRONTIERS IN MICROBIOLOGY (2018)
Progression and Treatment Outcomes of Lung Disease Caused by Mycobacterium abscessus and Mycobacterium massiliense
Jimyung Park et al.
CLINICAL INFECTIOUS DISEASES (2017)
Mycobacterial Characteristics and Treatment Outcomes in Mycobacterium abscessus Lung Disease
Won-Jung Koh et al.
CLINICAL INFECTIOUS DISEASES (2017)
Disinfectant Susceptibility Profiling of Glutaraldehyde-Resistant Nontuberculous Mycobacteria
Winona Burgess et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2017)
The new phylogeny of the genus Mycobacterium: The old and the news
Enrico Tortoli et al.
INFECTION GENETICS AND EVOLUTION (2017)
Targeting Mycolic Acid Transport by Indole-2-carboxamides for the Treatment of Mycobacterium abscessus Infections
Alan P. Kozikowski et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Amphiphilic Indole Derivatives as Antimycobacterial Agents: Structure-Activity Relationships and Membrane Targeting Properties
Tianming Yang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
MmpL3 is the flippase for mycolic acids in mycobacteria
Zhujun Xu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Reversion of antibiotic resistance in Mycobacterium tuberculosis by spiroisoxazoline SMARt-420
Nicolas Blondiaux et al.
SCIENCE (2017)
Genomic Insight into Mechanisms of Reversion of Antibiotic Resistance in Multidrug Resistant Mycobacterium tuberculosis Induced by a Nanomolecular Iodine-Containing Complex FS-1
Aleksandr I. Ilin et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2017)
Screening of TB Actives for Activity against Nontuberculous Mycobacteria Delivers High Hit Rates
Jian Liang Low et al.
FRONTIERS IN MICROBIOLOGY (2017)
Essentiality of mmpL3 and impact of its silencing on Mycobacterium tuberculosis gene expression
Giulia Degiacomi et al.
SCIENTIFIC REPORTS (2017)
Design, synthesis and evaluation of indole-2-carboxamides with pan anti-mycobacterial activity
Nicholas D. Franz et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2017)
Synergistic Interactions of MmpL3 Inhibitors with Antitubercular Compounds In Vitro
Wei Li et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Clofazimine Prevents the Regrowth of Mycobacterium abscessus and Mycobacterium avium Type Strains Exposed to Amikacin and Clarithromycin
Beatriz E. Ferro et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Tigecycline Potentiates Clarithromycin Activity against Mycobacterium avium In Vitro
Hannelore I. Bax et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Therapeutic Potential of the Mycobacterium tuberculosis Mycolic Acid Transporter, MmpL3
Wei Li et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Indole-2-carboxamide-based MmpL3 Inhibitors Show Exceptional Antitubercular Activity in an Animal Model of Tuberculosis Infection
Jozef Stec et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
A new piperidinol derivative targeting mycolic acid transport in Mycobacterium abscessus
Christian Dupont et al.
MOLECULAR MICROBIOLOGY (2016)
Structure of the Essential Mtb FadD32 Enzyme: A Promising Drug Target for Treating Tuberculosis
Misty L. Kuhn et al.
ACS INFECTIOUS DISEASES (2016)
Structure-Function Profile of MmpL3, the Essential Mycolic Acid Transporter from Mycobacterium tuberculosis
Juan Manuel Belardinelli et al.
ACS INFECTIOUS DISEASES (2016)
Diagnosis and Treatment of Nontuberculous Mycobacterial Lung Disease: Clinicians' Perspectives
Yon Ju Ryu et al.
TUBERCULOSIS AND RESPIRATORY DISEASES (2016)
Relapse versus Reinfection of Mycobacterium avium Complex Pulmonary Disease Patient Characteristics and Macrolide Susceptibility
Daniel P. Boyle et al.
ANNALS OF THE AMERICAN THORACIC SOCIETY (2016)
Risk Factors for Recurrence after Successful Treatment of Mycobacterium avium Complex Lung Disease
Bo Young Lee et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Synthesis and evaluation of in vitro antimycobacterial activity of novel 1H-benzo[d]imidazole derivatives and analogues
Katarzyna Gobis et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2015)
Nontuberculous Mycobacteria in Cystic Fibrosis and Non-Cystic Fibrosis Bronchiectasis
In Kwon Park et al.
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE (2015)
General Overview on Nontuberculous Mycobacteria, Biofilms, and Human Infection
Sonia Faria et al.
JOURNAL OF PATHOGENS (2015)
Novel Insights into the Mechanism of Inhibition of MmpL3, a Target of Multiple Pharmacophores in Mycobacterium tuberculosis
Wei Li et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Mycolic Acids: Structures, Biosynthesis, and Beyond
Hedia Marrakchi et al.
CHEMISTRY & BIOLOGY (2014)
New Approaches to Target the Mycolic Acid Biosynthesis Pathway for the Development of Tuberculosis Therapeutics
E. North et al.
CURRENT PHARMACEUTICAL DESIGN (2014)
N-Arylalkylbenzo[d]thiazole-2-carboxamides as anti-mycobacterial agents: design, new methods of synthesis and biological evaluation
Parth Shah et al.
MEDCHEMCOMM (2014)
Fueling Open-Source Drug Discovery: 177 Small-Molecule Leads against Tuberculosis
Lluis Ballell et al.
CHEMMEDCHEM (2013)
Preliminary Structure-Activity Relationships and Biological Evaluation of Novel Antitubercular Indolecarboxamide Derivatives Against Drug-Susceptible and Drug-Resistant Mycobacterium tuberculosis Strains
Oluseye K. Onajole et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Design, Synthesis, and Biological Evaluation of Indole-2-carboxamides: A Promising Class of Antituberculosis Agents
Ravinder Reddy Kondreddi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Antituberculosis thiophenes define a requirement for Pks13 in mycolic acid biosynthesis
Regina Wilson et al.
NATURE CHEMICAL BIOLOGY (2013)
Improved BM212 MmpL3 Inhibitor Analogue Shows Efficacy in Acute Murine Model of Tuberculosis Infection
Giovanna Poce et al.
PLOS ONE (2013)
Tetrahydropyrazolo[1,5-a]Pyrimidine-3-Carboxamide and N-Benzyl-6′,7′-Dihydrospiro[Piperidine-4,4′-Thieno[3,2-c]Pyran] Analogues with Bactericidal Efficacy against Mycobacterium tuberculosis Targeting MmpL3
Modesto J. Remuinan et al.
PLOS ONE (2013)
Diarylcoumarins inhibit mycolic acid biosynthesis and kill Mycobacterium tuberculosis by targeting FadD32
Sarah A. Stanley et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Indolcarboxamide Is a Preclinical Candidate for Treating Multidrug-Resistant Tuberculosis
Srinivasa P. S. Rao et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Chronic respiratory disease, inhaled corticosteroids and risk of non-tuberculous mycobacteriosis
Claire Andrejak et al.
THORAX (2013)
Indoleamides are active against drug-resistant Mycobacterium tuberculosis
Shichun Lun et al.
NATURE COMMUNICATIONS (2013)
Identification of Novel Inhibitors of M. tuberculosis Growth Using Whole Cell Based High-Throughput Screening
Sarah A. Stanley et al.
ACS CHEMICAL BIOLOGY (2012)
SQ109 Targets MmpL3, a Membrane Transporter of Trehalose Monomycolate Involved in Mycolic Acid Donation to the Cell Wall Core of Mycobacterium tuberculosis
Kapil Tahlan et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Inhibition of mycolic acid transport across the Mycobacterium tuberculosis plasma membrane
Anna E. Grzegorzewicz et al.
NATURE CHEMICAL BIOLOGY (2012)
Investigations of genotoxic activity of antimicrobial/antiviral agent FS-1 in human lymphocytes and tumor cell
A. Nersesyan et al.
CYTOLOGY AND GENETICS (2011)
Distinguishing Tuberculosis from Nontuberculous Mycobacteria Lung Disease, Oregon, USA
Brian A. Kendall et al.
EMERGING INFECTIOUS DISEASES (2011)
Bacterial growth and cell division: a mycobacterial perspective
Erik C. Hett et al.
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2008)
The Mycobacterium tuberculosis FAS-II condensing enzymes:: their role in mycolic acid biosynthesis, acid-fastness, pathogenesis and in future drug development
Apoorva Bhatt et al.
MOLECULAR MICROBIOLOGY (2007)
An official ATS/IDSA statement: Diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases
David E. Griffith et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2007)
Factors related to response to intermittent treatment of Mycobacterium avium complex lung disease
Phung K. Lam et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2006)
Pathway to synthesis and processing of mycolic acids in Mycobacterium tuberculosis
K Takayama et al.
CLINICAL MICROBIOLOGY REVIEWS (2005)
Acyl-CoA carboxylases (accD2 and accD3), together with a unique polyketide synthase (Cg-pks), are key to mycolic acid biosynthesis in corynebacterianeae such as Corynebacterium glutamicum and Mycobacterium tuberculosis
R Gande et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
分享论文
